<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <!-- Generated by Workiva -->
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001573785</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001936258</issuerCik>
      <issuerName>NewAmsterdam Pharma Company N.V.</issuerName>
      <secFileNumber>001-41562</secFileNumber>
      <issuerAddress>
        <com:street1>Gooimeer 2-35</com:street1>
        <com:city>DC Naarden</com:city>
        <com:stateOrCountry>P7</com:stateOrCountry>
        <com:zipCode>1411</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>31-0-35-206-2971</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Michael H. Davidson</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Affiliate</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>J.P. Morgan Securities LLC</name>
        <address>
          <com:street1>270 Park Avenue - 10th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10017</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>750000</noOfUnitsSold>
      <aggregateMarketValue>27127500</aggregateMarketValue>
      <noOfUnitsOutstanding>114975422</noOfUnitsOutstanding>
      <approxSaleDate>02/24/2026</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <acquiredDate>02/24/2025</acquiredDate>
      <natureOfAcquisitionTransaction>Option Exercise</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>750000</amountOfSecuritiesAcquired>
      <paymentDate>02/24/2026</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>The shares represented on this filing are for shares that the seller may acquire via option exercises and subsequently sold within 3 months of this filing.</remarks>
    <noticeSignature>
      <noticeDate>02/24/2026</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>09/29/2025</planAdoptionDate>
      </planAdoptionDates>
      <signature>/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Michael H. Davidson</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
